Co-metabolic degradation and metabolite detection of hexabromocyclododecane by Shewanella oneidensis MR-1

Abstract Hexabromocyclododecane (HBCD) is a widely used brominated flame retardant; however, it is a persistent organic pollutant as well as affects the human thyroid hormones and causes cancer. However, the degradation of HBCD has received little attention from researchers. Due to its bioaccumulative and hazardous properties, an appropriate strategy for its remediation is required. In this study, we investigated the biodegradation of HBCD using Shewanella oneidensis MR-1 under optimized conditions. The Box-Behnken design (BBD) was implemented for the optimization of the physical degradation parameters of HBCD. S. oneidensis MR-1 showed the best degradation performance at a temperature of 30 °C, pH 7, and agitation speed of 115 rpm, with an HBCD concentration of 1125 μg/L in mineral salt medium (MSM). The strain tolerated up to 2000 μg/L HBCD. Gas chromatography-mass spectrometry analysis identified three intermediates, including 2-bromo dodecane, 2,7,10-trimethyldodecane, and 4-methyl-1-decene. The results provide an insightful understanding of the biodegradation of HBCD by S. oneidensis MR-1 under optimized conditions and could pave the way for further eco-friendly applications. Key points • HBCD biodegradation by Shewanella oneidensis • Optimization of HBCD biodegradation by the Box-Behnken analysis • Identification of useful metabolites from HBCD degradation.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:108

Enthalten in:

Applied microbiology and biotechnology - 108(2023), 1 vom: 29. Dez.

Sprache:

Englisch

Beteiligte Personen:

Shah, Syed Bilal [VerfasserIn]
Wang, Yiting [VerfasserIn]
Anwar, Naveed [VerfasserIn]
Abbas, Syed Zaghum [VerfasserIn]
Khan, Khalid Ali [VerfasserIn]
Wang, Song-Mei [VerfasserIn]
Ullah, Muhammad Wajid [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Co-metabolic degradation
Hexabromocyclododecane
Intermediates
MR-1
Metabolic pathway

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s00253-023-12905-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR054203112